Max Quantity by Drug 120
Max Qty: Oxycontin – 120/fill Quantity Maximum (960 mg max total per day) – NCPDP 76 – Plan Limitations Exceeded – Call BCCDT at (410) 767-6787
|
GSN = 024505, 024506, 025702, 024504, 045129
|
|
| Max Quantity by Drug –Duragesic
Max Qty: Duragesic Patches – 20/fill Qty Maximum – NCPDP 76 – Plan Limitations Exceeded – Call BCCDT at (410) 767-6787
|
HSN = 006438
|
Duragesic Patches (all strengths)
|
| Max Quantity by Drug – Max qty = 4000
Max Qty: 4000 – NCPDP 76 – Plan Limitations Exceeded
|
GSN 003062
|
Sod Sulf/Sod/NaHCO#/KCL/Pegs
|
|
GSN 019656
|
Sod Chloride/NaHCO3/Pegs
|
| Max Quantity by Drug – Max qty = 4050
Max Qty: 4050 - NCPDP 76 – Plan Limitations Exceeded
|
GSN 024953
|
Sod Sulf/Sod/NaHCO3/KCL/Pegs
|
| Max Quantity by Drug – Max qty = 120 / 34 days
Max Qty: Actiq - NCPDP 76 – Plan Limitations Exceeded
|
HSN 01747
|
Actiq MCG Lozenge
|
|
Max Quantity by Drug – Antiemetics
Max Qty: Antiemetic 10 tabs per month Qty Maximum – NCPDP 76 – Plan Limitations Exceeded – Call BCCDT at (410) 767-6787 (Qty is a combined qty limit of 10 tabs per month of all GSNs listed below.)
|
GSN=34749
|
Anzemet 50mg tabs
|
|
GSN=34750
|
Anzemet 100mg tabs
|
|
GSN=43230
|
Zofran 24mg tabs
|
|
Max Qty: Antiemetic 15 tabs per month Qty Maximum – NCPDP 76 – Plan Limitations Exceeded – Call BCCDT at (410) 767-6787 (Qty is a combined qty limit of 15 tabs per month of all GSNs listed below.)
|
GSN = 21592
|
Kytril 1.0mg tabs
|
|
GSN= 51911
|
Emend 80 mg caps
|
|
GSN=51912
|
Emend 125mg caps
|
|
GSN=51913
|
Emend 125-80mg caps Trifold Pack
|
|
|
|
|
Max Qty: Zofran 30 tabs per month Qty Maximum – NCPDP 76 – Plan Limitations Exceeded – Call BCCDT at (410) 767-6787 (Qty is a combined qty limit of 30 tabs per month of all GSNs listed below.)
|
GSN=16392 – Own Category
|
Zofran 4mg tabs
|
|
GSN=16393
|
Zofran 8mg tabs
|
|
GSN=41562
|
Zofran ODT 4mg
|
|
GSN=41563
|
Zofran ODT 8mg tabs
|
|
Max Qty: Antiemetic 75 ml per month Qty Maximum – NCPDP 76 – Plan Limitations Exceeded – Call BCCDT at (410) 767-6787
|
GSN = 28107
|
Zofran 4mg/ml solution
|
|
Max Qty: Antiemetic 150 ml per month Qty Maximum – NCPDP 76 – Plan Limitations Exceeded – Call BCCDT at (410) 767-6787
|
GSN = 21592
|
Kytril 1.0mg/5ml solution
|
|
Max Days 102
Max Days 102 - NCPDP 76- Plan Limitations Exceeded (includes Maintenance Medications)
For PA, call BCCDT at 410-767-6787
|
DEA = 2
|
All Schedule II Narcotics
|
|
GSN = 004964, 044980
|
Leuprolide 3-month kit
|
|
DCC = R
|
Insulin Syringes
|
|
AHFS = 24:04
|
Cardiac Drugs
|
|
AHFS = 24:08
|
Hypotensive agents
|
|
AHFS = 24:08.16
|
Central Alpha-Agonists
|
|
AHFS = 24:08.20
|
Direct Vasodilators
|
|
AHFS = 24:08.32
|
Peripheral Adrenergic Inhibitors
|
|
AHFS = 24:08.92
|
Misc. Hypotensive Agents
|
|
AHFS = 24:12.08
|
Vasodilating Agents
|
|
HIC3 = C1D
|
AHFS 40:12 (Replacement Solutions)
Potassium supplements only
|
Listed products only
|
AHFS = 40:28
|
Diuretics
|
|
AHFS = 68:20.08
|
Insulins
|
|
AHFS = 68:20.20
|
Sulfonylureas
|
|
AHFS = 68:36.04
|
Thyroid Agents
|
|
HSN = 001879, 001878, 001877
|
AHFS 28:12.12 (Hydantoins)
Phenytoin
Phenytoin Sodium
|
Listed products only
|
Route = oral
|
AHFS 20:04.04 (Iron preparations)
Oral products in which ferrous sulfate is the only active ingredient
|
Listed products only
Note: OTC is not a requirement for these chewable Fe products (per regs)
|
AHFS = 24:20
|
Alpha-Adrenergic Blocking Agents
|
|
AHFS = 24:24
|
Beta-Adrenergic Blocking Agents
|
|
AHFS = 24:28
|
Calcium-Channel Blocking Agents
|
|
AHFS = 24:32
|
Renin-Angiotensin System Inhibitors
|
|
AHFS = 24:32.04
|
Angiotensin-Converting Enzyme Inhibitors
|
|
AHFS = 24:32.08
|
Angiotensin II Receptor Antagonists
|
|
|
|
|
HSN 003926
|
Tamoxifen
|
|
HSN 010249
|
Anastrozole (Arimidex)
|
|
OTC Drug Coverage
OTC drugs are generally not covered by BCCDT but there are exceptions and they are in the grid below:
OTC Exception List – All OTCs to deny w/ NCPDP 70 – Drug Not Covered w/the exception of the products listed below
|
Drug Code
|
Drug Name
|
Comments
|
HIC3 = C5U
|
Nutritional Therapy, Med Cond Special Electrolytes & Misc. Nutrients
|
Includes products for disease-specific nutritional therapy
|
HIC3 = C5F
|
Dietary Supplements
|
Includes Ensure-type products
|
HIC3 = C1W
|
Electrolyte Maintenance
|
Includes electrolyte solutions
|
HIC3 = C5G
|
Food Oils
|
Includes corn, safflower oils
|
HIC3 = M4B
|
IV Fat Emulsions
|
|
GSN 011832, 001645, 001646, 017378
|
Ferrous Sulfate
|
OTC TO COVER
|
MEDICARE B
BCCDT will cost avoid for Medicare B covered drugs
The system will deny COB claims for Medicare B recipients if the Other Coverage Code is not equal to ‘2’ with edit 41 (bill other insurance) and the message text: “Bill Medicare B“.
The following is a list of drugs covered by Medicare B:
Code Level Code Values
|
Drug Code
|
Oral Chemotherapy
|
|
GSN = 008838
|
VePesid (Etoposide)
|
|
GSN = 008770, 008771
|
Cytoxan (Cyclophosphamide)
|
|
GSN = 008773
|
Alkeran (Melphalan)
|
|
GSN = 036872, 045266, 035928, 036874, 047823, 047824
|
Methotrexate
|
|
HSN = 018385
|
Xeloda (Capecitabine)
|
|
Qualified Medicare Beneficiary (QMB) Recipients
The system will pay coinsurance for QMB recipients if claims contain another coverage code of 3 or 4 for Med-B covered drugs only.
ACS will ensure that QMB recipients have pharmacy coverage except for drugs covered by Medicare B such as Xeloda- then BCCDT pays only denied claims. Pharmacies then must bill Medicare and then Medicaid and BCCDT will be the payer of last resort for coinsurance.
The system will reject QMB claims where the Other Coverage Code is not equal to ‘3-4’; the response will contain reject code edit 70 (Drug Not Covered) and the message text “BCCDT Only Reimburses Non-Covered Medicare B covered drugs"
MEDICARE D
BCCDT will cost avoid for Medicare D recipients. Providers are required to ensure COB claims for Medicare D to contain “77777” in the Other Payer ID (NCPDP field 340-7C). The Other Payer ID is not required for non-Medicare D carriers.
Drugs not covered by Medicare D that may be covered by BCCDT. Some require prior authorization.
Medical Supplies
|
TC
|
00
Exceptions:
Part D Must Cover
GSN = 009797
HSN = 004348
HSN = 008966
DCC = Q, R
|
A
gents used for
anorexia, weight
loss or weight gain
|
DCC
|
F
|
Agents used for symptomatic relief of cough/cold
|
TC
|
16
17
|
Rx vitamins and minerals, except prenatal vitamins and fluoride products
|
TC
|
80
81
82(Except HIC3=C6F)
83
84
85
|
OTC
|
Rx Required Field
|
N = OTC Drugs
Exceptions:
Part D Must Cover
HSN = 011115 & OTC
HSN = 007605 & OTC & Generic
|
Benzodiazepines:
|
|
|
Alprazolam
|
HSN
|
001617
|
Chlordiazepoxide
|
HSN
|
001611
|
|
HSN
|
001610
|
Clorazepate
|
HSN
|
001612
|
Diazepam
|
HSN
|
001615
|
Halazepam
|
HSN
|
001618
|
Lorazepam
|
HSN
|
004846
|
Oxazepam
|
HSN
|
001616
|
Prazepa
m
|
HSN
|
001613
|
Estazolam
|
HSN
|
006036
|
Flurazepam
|
HSN
|
001593
|
Midazolam
|
HSN
|
001619
|
Quazepam
|
HSN
|
001595
|
Temazepam
|
HSN
|
001592
|
Triazolam
|
HSN
|
001594
|
Clonazepam
|
HSN
|
001894
|
COPAY Only Claim Submission
BCCDT will allow for the submission of copay only claims but the following rules must be followed in order for the claim to be reimbursed:
There is a $60.00 maximum on all copay only claims. Claims submitted for amounts greater than the maximum will have to be approved by BCCDT.
BCCDT will pay co-payments for PAC recipients if claims contain an "8" in NCPDP field 308-C8, Other Coverage Code.
The system will reject PAC claims where the Other Coverage Code is not equal to ‘8’ (Copay Only) with reject code edit 70 (Drug Not Covered) and the message text “BCCDT Only Reimburses Co-payments – Please bill PAC
The following fields must be populated when submitting a copay only claim:
Other Coverage Code (308-C8) = 8
Other Amount Claimed Submitted Count = 1
Other Amount Claimed Submitted Qualifier = 99
Other Amount Claimed Submitted = copay amount and must equal the amount in Gross Amount Due
Gross Amount Due = copay amount and must equal the amount in the Other Amount Claimed Submitted
**No COB Segment is submitted with a Copay only claim.
Generic Mandatory
BCCDT has a generic mandatory program in place. The system will deny brand drugs when a generic is available with edit 22 (M/I Dispense As Written/DAW code) when submitted as Brand Medically Necessary (DAW = 1).
The system will accept the following Dispense as Written (DAW) values (NCPDP field 408-D8):
0 - default, no product selection
1 - Physician request
5 - Brand used as generic
PRODUR EDITS:
BCCDT will deny for Therapeutic Duplication (TD) and Early Refill (ER) only. Alert messages will be returned for other ProDUR problem types.
ProDUR edits that deny may be overridden by the pharmacy provider at POS using the interactive NCPDP DUR override codes for selected conflict types.
To request an Early Refill override, contact AFFILIATED COMPUTER SERVICES, INC.: 1-800-932-3918.
Days supply information is critical to the edit functions of the ProDUR system. Submitting incorrect days supply information in the days supply field can cause false ProDUR messages or claim denial for that particular claim or for drug claims that are submitted in the future.
Technical Call Center:
Affiliated Computer Services’ Technical Call Center is available 24 hours per day, seven days per week.
The telephone number is: 1-800-932-3918
Alert message information is available from the Call Center after the message appears. If you need assistance with any alert or denial messages, it is important to contact the Call Center about Affiliated Computer Services’ ProDUR messages at the time of dispensing. The Call Center can provide claims information on all error messages which are sent by the ProDUR system. This information includes: NDCs and drug names of the affected drugs, dates of service, whether the calling pharmacy is the dispensing pharmacy of the conflicting drug, and days supply.
The Technical Call Center is not intended to be used as a clinical consulting service and cannot replace or supplement the professional judgment of the dispensing pharmacist. AFFILIATED COMPUTER SERVICES, INC has used reasonable care to accurately compile ProDUR information. Because this information is unique; it is intended for pharmacists to use at their own discretion in the drug therapy management of their patients.
Affiliated Computer Services’ ProDUR is an integral part of the BCCDT Program’s claims adjudication process. ProDUR includes: reviewing claims for therapeutic appropriateness before the medication is dispensed, reviewing the available medical history, focusing on those patients at the highest severity of risk for harmful outcome, and intervening and/or counseling when appropriate.
Share with your friends: |